Literature DB >> 26629368

Genes and Cardiovascular Disease: Where do we go from here?

Sunil K Nadar1, Kully Sandhu2.   

Abstract

Entities:  

Year:  2015        PMID： 26629368      PMCID： PMC4664086          DOI： 10.18295/squmj.2015.15.04.001

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN： 2075-051X


× No keyword cloud information.
  24 in total

Review 1.  Genomics of cardiovascular disease.

Authors:  Christopher J O'Donnell; Elizabeth G Nabel
Journal:  N Engl J Med       Date:  2011-12-01       Impact factor: 91.245

2.  Ethical issues in predictive genetic testing: a public health perspective.

Authors:  K G Fulda; K Lykens
Journal:  J Med Ethics       Date:  2006-03       Impact factor: 2.903

Review 3.  Epigenetic-related therapeutic challenges in cardiovascular disease.

Authors:  Concetta Schiano; Maria Teresa Vietri; Vincenzo Grimaldi; Antonietta Picascia; Maria Rosaria De Pascale; Claudio Napoli
Journal:  Trends Pharmacol Sci       Date:  2015-03-07       Impact factor: 14.819

4.  Frequencies of the Arg16Gly, Gln27Glu and Thr164Ile Adrenoceptor β2 Polymorphisms among Omanis.

Authors:  Khalid Al-Balushi; Fahad Zadjali; Sawsan Al-Sinani; Al-Muatasim Al-Zadjali; Riad Bayoumi
Journal:  Sultan Qaboos Univ Med J       Date:  2015-11-23

Review 5.  The role of prophylactic surgery in cancer prevention.

Authors:  Y Nancy You; Vipul T Lakhani; Samuel A Wells
Journal:  World J Surg       Date:  2007-03       Impact factor: 3.352

Review 6.  Psychological consequences of predictive genetic testing: a systematic review.

Authors:  M Broadstock; S Michie; T Marteau
Journal:  Eur J Hum Genet       Date:  2000-10       Impact factor: 4.246

Review 7.  Predictive genetic testing for coronary artery disease.

Authors:  Christopher T Johansen; Robert A Hegele
Journal:  Crit Rev Clin Lab Sci       Date:  2009       Impact factor: 6.250

Review 8.  Beta 1- and beta 2-adrenoceptor polymorphisms and cardiovascular diseases.

Authors:  Kirsten Leineweber; Gerd Heusch
Journal:  Br J Pharmacol       Date:  2009-05-05       Impact factor: 8.739

9.  Genomewide association study using a high-density single nucleotide polymorphism array and case-control design identifies a novel essential hypertension susceptibility locus in the promoter region of endothelial NO synthase.

Authors:  Erika Salvi; Zoltán Kutalik; Nicola Glorioso; Paola Benaglio; Francesca Frau; Tatiana Kuznetsova; Hisatomi Arima; Clive Hoggart; Jean Tichet; Yury P Nikitin; Costanza Conti; Jitka Seidlerova; Valérie Tikhonoff; Katarzyna Stolarz-Skrzypek; Toby Johnson; Nabila Devos; Laura Zagato; Simonetta Guarrera; Roberta Zaninello; Andrea Calabria; Benedetta Stancanelli; Chiara Troffa; Lutgarde Thijs; Federica Rizzi; Galina Simonova; Sara Lupoli; Giuseppe Argiolas; Daniele Braga; Maria C D'Alessio; Maria F Ortu; Fulvio Ricceri; Maurizio Mercurio; Patrick Descombes; Maurizio Marconi; John Chalmers; Stephen Harrap; Jan Filipovsky; Murielle Bochud; Licia Iacoviello; Justine Ellis; Alice V Stanton; Maris Laan; Sandosh Padmanabhan; Anna F Dominiczak; Nilesh J Samani; Olle Melander; Xavier Jeunemaitre; Paolo Manunta; Amnon Shabo; Paolo Vineis; Francesco P Cappuccio; Mark J Caulfield; Giuseppe Matullo; Carlo Rivolta; Patricia B Munroe; Cristina Barlassina; Jan A Staessen; Jacques S Beckmann; Daniele Cusi
Journal:  Hypertension       Date:  2011-12-19       Impact factor: 10.190

Review 10.  Asthma genetics and personalised medicine.

Authors:  Deborah A Meyers; Eugene R Bleecker; John W Holloway; Stephen T Holgate
Journal:  Lancet Respir Med       Date:  2014-05-02       Impact factor: 30.700
View more
  1 in total

1.  Molecular assessment of some cardiovascular genetic risk factors among Iraqi patients with ischemic heart diseases.

Authors:  Wisam Jasim Mohammed; Bassam Musa Sadik Al-Musawi; Christian Oberkanins; Helene Pühringer
Journal:  Int J Health Sci (Qassim)       Date:  2018 May-Jun
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.